Postoperative Radiotherapy in Bladder Cancer Patients: 5-Year Institutional Experience of National Cancer Institute, Cairo University

Azza M. Nasr¹, Magda El Mongi¹, Mamdouh Hagag², Manar M. Moneer³, Hisham El Hossieny^1*, Azza Taher¹, Sherif Magdy¹

¹Radiation Oncology Department, National Cancer Institute, Cairo University, Giza, Egypt.
²Clinical Oncology Department, Faculty of Medicine, Cairo University, Giza, Egypt.
³Cancer Epidemiology and Biostatistics Department, National Cancer Institute, Cairo University, Giza, Egypt.

DOI: 10.4236/jct.2015.67063                

Abstract

Purpose: Adjuvant radiation therapy could reduce loco regional failure, but currently has no defined role because of previously reported morbidity. NCI-Cairo routine work is to give adjuvant PORT for locally advanced bladder carcinoma patients. The aim of this work is to re-evaluate this protocol regarding its effect on prognosis and complications. Patients and Method: A retrospective study included 208 patients with pathologically proven bladder cancer who presented to the NCI, Cairo University from 2007-2011. All of them underwent RC with bilateral PLND followed by conventional post-operative radiotherapy in 2 - 6 weeks after surgery for 5000 cGy in 25 fractions, over 5 weeks using 2D technique. Analysis of data from their files was done for the treatment results, prognostic factors and complications. Results: Three years overall survival (OS) and disease free survival (DFS) for the whole group was ~60%, and 54% respectively in favour of the female gender, non-smokers, Squamous cell carcinoma patients, low grade tumours (grade 1 and 2) negative margins, N0, pT2b and early stage group showed the best prognoses. The 3 years metastases free survival (MFS) was ~71%. Only four factors showed a significant relation with the MFS which were the grade, LN status, T-stage and group staging. The local recurrence rate (LRC) at 2 years for the whole group was ~95% and 94% at 3 years. Only surgical margin status and extent of LN dissection had a significant impact on the LRC. Conclusions: Adjuvant radiotherapy shows sustained improvement in the loco regional control, and should be recommended for patients with locally advanced disease especially those with less than 10 dissected lymph nodes and those with positive margins.

Keywords

Bladder Cancer, Radiotherapy, Pelvic Irradiation

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Griffiths, T.R.L. (2013) Current Perspectives in Bladder Cancer Management on Behalf of Action on Bladder Cancer. International Journal of Clinical Practice, 65, 435-448.
[2]	Ploeg, M., Aben, K.K. and Kiemeney, L.A. (2009) The Present and Future Burden of Urinary Bladder Cancer in the World. World Journal of Urology, 27, 289-293. http://dx.doi.org/10.1007/s00345-009-0383-3
[3]	Bolenz, C., Ho, R., Nuss, G.R., et al. (2010) Management of Elderly Patients with Urothelial Carcinoma of the Bladder: Guideline Concordance and Predictors of Overall Survival. BJU International, 106, 1324-1329. http://dx.doi.org/10.1111/j.1464-410X.2010.09417.x
[4]	Stein, J.P. and Skinner, D.G. (2006) Radical Cystectomy for Invasive Bladder Cancer: Long-Term Results of a Standard Procedure. World Journal of Urology, 24, 296-304. http://dx.doi.org/10.1007/s00345-006-0061-7
[5]	Abol-Enein, H., et al. (2005) Neoadjuvant Chemotherapy for Invasive Bladder Cancer. Cochrane Database of Systematic Reviews, Article ID: CD005246.
[6]	Pollack, A., Zagars, G.K., Cole, C.J., et al. (1995) The Relationship of Local Control to Distant Metastasis in Muscle Invasive Bladder Cancer. Journal of Urology, 154, 2059-2063. http://dx.doi.org/10.1016/S0022-5347(01)66693-X
[7]	Ide, H., Kikuchi, E., Miyajima, A., et al. (2008) The Predictors of Local Recurrence after Radical Cystectomy in Patients with Invasive Bladder Cancer. Japanese Journal of Clinical Oncology, 38, 360-364. http://dx.doi.org/10.1093/jjco/hyn036
[8]	Zaghloul, M.S., Awwad, H.K., Akoush, H.H., et al. (1992) Postoperative Radiotherapy of Carcinoma in Bilharzial Bladder: Improved Disease Free Survival through Improving Local Control. International Journal of Radiation Oncology*Biology*Physics, 23, 511-517. http://dx.doi.org/10.1016/0360-3016(92)90005-3
[9]	Reisinger, S.A., Mohiuddin, M. and Mulholland, S.G. (1992) Combined Pre- and Postoperative Adjuvant Radiation Therapy for Bladder Cancer a Ten Year Experience. International Journal of Radiation Oncology*Biology*Physics, 24, 463-468. http://dx.doi.org/10.1016/0360-3016(92)91060-Z
[10]	Zaghloul, M.S., Awwad, H.K., Soliman, O., et al. (1986) Postoperative Radiotherapy of Carcinoma in Bilharzial Bladder Using a Three-Fractions per Day Regimen. Radiotherapy Oncology, 6, 257-265. http://dx.doi.org/10.1016/S0167-8140(86)80192-X
[11]	Spera, J.A., Whittington, R., Littman, P., Solin, L.J. and Wein, A.J. (1988) A Comparison of Preoperative Radiotherapy Regimens for Bladder Carcinoma. The University of Pennsylvania Experience. Cancer, 61, 255-262. http://dx.doi.org/10.1002/1097-0142(19880115)61:2<255::AID-CNCR2820610210>3.0.CO;2-X
[12]	Baumann, B.C., Guzzo, T.J., He, J., Keefe, S.M., Tucker, K., Bekelman, J.E., Hwang, W.T., Vaughn, D.J., Malkowicz, S.B. and Christodouleas, J.P. (2013) A Novel Risk Stratification to Predict Local-Regional Failures in Urothelial Carcinoma of the Bladder after Radical Cystectomy. International Journal of Radiation Oncology * Biology * Physics, 85, 81-88.
[13]	Herr, H.W., Faulkner, J.R., Grossman, H.B., Natale, R.B., de Vere White, R., Sarosdy, M.F. and Crawford, E.D. (2004) Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report. Journal of Clinical Oncology, 22, 2781-2789. http://dx.doi.org/10.1200/JCO.2004.11.024
[14]	Zaghloul, M.S., Mohran, T.Z., Saber, R.A. and Agha, N. (2002) Postoperative Radiotherapy in Bladder Cancer. Journal of the Egyptian National Cancer Institute, 14, 161-168.
[15]	Cox, J.D., Stetz, J. and Pajak, T.F. (1995) Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology * Biology * Physics, 31, 1341-1346. http://dx.doi.org/10.1016/0360-3016(95)00060-C
[16]	Dawson, B. and Trapp, R.G., Eds. (2004) Basic and Clinical Biostatistics. 4th Edition, McGraw-Hill Professional, New York.
[17]	Ibrahim, A.S., Khaled, H.M., Mikhail, N.N., Baraka, H. and Kamel, H. (2014) Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. Journal of Cancer Epidemiology, 2014, Article ID: 437971. http://dx.doi.org/10.1155/2014/437971
[18]	Efstathiou, J.A., Zietman, A.L., Coen, J.J. and Shipley, W.U. (2012) Chapter 52: Bladder Cancer. In: Gunderson, L.L. and Tepper, J.E., Eds., Clinical Radiation Oncology, Third Edition, Elsevier, Amsterdam, 1000-1123.
[19]	Gouda, I., Mokhtar, N., Bilal, D., El-Bolkainy, T. and El-Bolkainy, N.M. (2007) Bilharziasis and Bladder Cancer: A Time Trend Analysis of 9843 Patients. Journal of the Egyptian National Cancer Institute, 19, 158-162.
[20]	Tracey, E., Roder, D., Luke, C. and Bishop, J. (2009) Bladder Cancer Survivals in New South Wales, Australia: Why Do Women Have Poorer Survival than Men? BJU International, 104, 498-504. http://dx.doi.org/10.1111/j.1464-410X.2009.08527.x
[21]	Shariat, S.F., Sfakianos, J.P., Droller, M.J., Karakiewicz, P.I., Meryn, S. and Bochner, B.H. (2010) The Effect of Age and Gender on Bladder Cancer: A Critical Review of the Literature. BJU International, 105, 300-308. http://dx.doi.org/10.1111/j.1464-410X.2009.09076.x
[22]	May, M., Stief, C., Brookman-May, S., Otto, W., Gilfrich, C., Roigas, J., et al. (2012) Gender-Dependent Cancer-Specific Survival Following Radical Cystectomy. World Journal of Urology, 30, 707-713. http://dx.doi.org/10.1007/s00345-011-0773-1
[23]	Otto, W., May, M., Fritsche, H.M., Dragun, D., Aziz, A., Gierth, M., et al. (2012) Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder. Gender Medicine, 9, 481-489. http://dx.doi.org/10.1016/j.genm.2012.11.001
[24]	Balci, U., Ozer, K., Gorgel, S.N., Sefik, E., Girgin, C. and Dincel, C. (2013) Do Pure Squamous Cell Carcinomas and Urothelial Carcinomas Have Similar Prognosis after Radical Cystectomy? World Journal of Urology, 31, 1177-1182. http://dx.doi.org/10.1007/s00345-012-0872-7
[25]	Cozzarini, C., Pelegrini, D., Fallini, M., Mandelli, D., Rosso, A., Bertini, R., et al. (1999) Reappraisal of the Role of Adjuvant Radiotherapy in Muscle-Invasive Transitional Cell Carcinoma of the Bladder. International Journal of Radiation Oncology * Biology * Physics, 45, 221-222. http://dx.doi.org/10.1016/S0360-3016(99)90162-1
[26]	Zaghloul, M.S., El Baradie Nouh, M.A., Abdel-Fatah, S., Taher, A. and Shalaan, M. (2007) Prognostic Index for Primary Adenocarcinoma of the Urinary Bladder. Gulf Journal of Oncology, 1, 47-54.
[27]	Zaghloul, M. (2010) Adjuvant and Neoadjuvant Radiotherapy for Bladder Cancer: Revisited. Future Oncology, 6, 1177-1191. http://dx.doi.org/10.2217/fon.10.82
[28]	Ghoneim, M.A., Abdel-Latif, M., El-Mekresh, M., Abol-Enein, H., Mosbah, A., Ashamallah, A. and el-Baz, M.A. (2008) Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Year Later. Journal of Urology, 180, 121-127. http://dx.doi.org/10.1016/j.juro.2008.03.024
[29]	Zaghloul, M.S., Nouh, A., Nazmy, M., Ramzy, S., Zaghloul, A.S., Sedira, M.A. and Khalil, E. (2006) Long-Term Results of Primary Adenocarcinoma of the Urinary Bladder: A Report on 192 Patients. Urologic Oncology, 24, 13-20. http://dx.doi.org/10.1016/j.urolonc.2005.05.027